FGAM
TEVA icon

Financial Gravity Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Gravity Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$0 Hold
10
– – ﹤0.01% 1609
2018
Q2 		$0 Sell
10
-1
-9% -$20 ﹤0.01% 1599
2018
Q1 		$0 Buy
+11
New +$215 ﹤0.01% 1497

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Financial Gravity Asset Management's TEVA Position: Q3 2018 in Review

Financial Gravity Asset Management held its Teva Pharmaceuticals (TEVA) position steady in Q3 2018 at 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

Financial Gravity Asset Management first reported a position in TEVA in Q1 2018 and has held it in 3 quarters since. 557 funds tracked by Wall St. Rank hold TEVA as of Q3 2018.

  • Financial Gravity Asset Management held 10 shares of Teva Pharmaceuticals worth $0 as of Q3 2018.
  • Financial Gravity Asset Management left its Teva Pharmaceuticals share count unchanged in Q3 2018.
  • Teva Pharmaceuticals made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q3 2018, its #1609 holding.
  • Financial Gravity Asset Management first reported a position in Teva Pharmaceuticals in Q1 2018 and has held it in 3 quarters since.
  • 557 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2018.

Based on Financial Gravity Asset Management's 13F filing for Q3 2018, filed 31 Oct 2018.